Dhifaf Sarhan
Senior Lecturer | Docent
E-mail: dhifaf.sarhan@ki.se
Visiting address: ,
Postal address: H5 Laboratoriemedicin, H5 Patologi, 141 52 Huddinge
About me
- Dhifaf Sarhan is Associate Professor (Docent), Group leader at the
Department of Laboratory Medicine Huddinge (LABMED)/Division of Pathology, and the Division Head.
Sarhan was recruited to the Department of Microbiology, Tumor and Cell
biology as Assistant Professor in Tumor immunology/Immunotherapy in 2019 and
as group leader at LABMED/Division of Pathology in 2021 focusing on deciphering immune interactions and responses in solid tumors. Sarhan completed her Ph.D. at the Department of Oncology-Pathology, Karolinska Institutet in
2014 focused on studying natural killer (NK) cells in the tumor microenvironment followed by postdoctoral training at the University of
Minnesota. Her group research interest focuses on studying the
consequences of the tumor microenvironment (TME) on shaping the immune
effector cell function and memory aiming to remodel the TME to improved
cancer immunotherapies in a sex-dependent manner.
Honors and awards
Junior Investigator Award, Swedish Cancer Society
Jonas Söderquist's scholarship
Selected for 3-years CANCER CORE EUROPE advanced training program TRYTRAC in
translational/clinical research and leadership
World Immunotherapy Council, Young Investigator Award
Best abstract, Cancer immunotherapy and immunomonitoring (CITIM)
Pancreatic cancer fellow, Swedish Cancer Society
Postdoctoral fellowship, Karolinska Institutet and University of Minnesota,
Minneapolis, Minnesota USA
Award for research project, ImmunoTools
Scholarship, Swedish Order of Freemasons
Funding
Current:
Centrum for Innovative Medicine
Swedish Cancer Society
Radiumhemmetsforsknings fonder
Stiftelsen Clas Groschinsky Minnesfonds
KI Stiftelser och Fonder
Stiftelsen Sigurd and Elsa Goljes Minne
The Sjöberg foundation
Past:
Jonas Söderquist foundation
Postdoctoral fellowship Karolinska Institutet, University of Minnesota
Novo, NovoSeeds
Lindhes Advokatbyrå
Robert Lundbergs minnesstiftelse
Education
2010-2014- PhD, Medical Sciences, Karolinska Institutet, Stockholm, Sweden
2008-2010: M.S, Biomedicine, Karolinska Institutet
2005-2008: B.S Molecular biology, Uppsala University, Uppsala, Sweden
Teaching assignments
Medicine program, Biomedical science program, Biomedical laboratory science, and doctoral education.
Research
- *Research line I: Adaptive NK cell immunological memory in cancer*
For decades NK cells were believed to lack the immunological memory, however
recent groundbreaking research by us and others revealed the opposite. We
discovered novel mechanisms used by a subset of NK cells with immunological
memory, called adaptive NK cells, to resist the suppressive tumor
environment. In this project we focus on investigating the molecular
mechanisms behind NK cell memory to tumors and the crosstalk with antigen
presenting cells like dendritic cells and B cells in cancer.
*Research Line II: Studies of sex immune dimorphism in the TME
We found that a G-protein coupled receptor has predictive value for female
cancer patients and induce immune cell exhaustion. Hormone regulation of the ligand for this
receptor has been shown to induce anti-inflammatory properties in
macrophages. We revealed that this receptor impacts the immune landscape in pancreatic
cancer TME biased by sex dimorphism. Extensive examination of the signal
integration is needed to further elucidate its mechanism of action and
clinical impact.
Teaching
- Teaching in immunology and tumor immunology at Karolinska Institutet and
Uppsala University.
Articles
- Article: TRANSLATIONAL ONCOLOGY. 2025;59:102462Gultekin O; Gonzalez-Molina J; Sarhan D; Groes-Kofoed N; Ul Hassan M; Lehti K; Salehi S
- Article: CANCER IMMUNOLOGY RESEARCH. 2025;13(7):1080-1097Sun Y; Furones AR; Gultekin O; Khare S; Neo SY; Shi W; Moyano-Galceran L; Lam K-P; Dasgupta R; Fuxe J; Salehi S; Lehti K; Sarhan D
- Article: NATURE COMMUNICATIONS. 2024;15(1):3837Wang K; Zerdes I; Johansson HJ; Sarhan D; Sun Y; Kanellis DC; Sifakis EG; Mezheyeuski A; Liu X; Loman N; Hedenfalk I; Bergh J; Bartek J; Hatschek T; Lehtio J; Matikas A; Foukakis T
- Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1230718Almazan NM; Sala BM; Sandalova T; Sun Y; Resink T; Cichocki F; Soderberg-Naucler C; Miller JS; Achour A; Sarhan D
- Article: CANCER RESEARCH. 2023;83(10):1628-1645He F; Tay AHM; Calandigary A; Malki E; Suzuki S; Liu T; Wang Q; Fernandez-Moro C; Kaisso M; Olofsson-Sahl P; Melssen M; Sze SK; Bjornstedt M; Lohr MJ; Karlsson MCI; Heuchel R; Sarhan D
- Article: ISCIENCE. 2022;25(11):105317Sarhan D; Eisinger S; He F; Bergsland M; Pelicano C; Driescher C; Westberg K; Benitez II; Humoud R; Palano G; Li S; Carannante V; Muhr J; Onfelt B; Schlisio S; Ravetch JV; Heuchel R; Lohr MJ; Karlsson MCI
- Article: SEMINARS IN CANCER BIOLOGY. 2022;86(Pt 3):166-179He F; Furones AR; Landegren N; Fuxe J; Sarhan D
- Article: NPJ PRECISION ONCOLOGY. 2021;5(1):97Gultekin O; Gonzalez-Molina J; Hardell E; Moyano-Galceran L; Mitsios N; Mulder J; Kokaraki G; Isaksson A; Sarhan D; Lehti K; Carlson JW
- Article: EMBO REPORTS. 2021;22(3):e51329Chen Z; Yang Y; Neo SY; Shi H; Chen Y; Wagner AK; Larsson K; Tong L; Jakobsson P-J; Alici E; Wu J; Cao Y; Wang K; Liu LL; Mao Y; Sarhan D; Lundqvist A
- Article: CANCER RESEARCH. 2021;81(4):956-967La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
- Article: IMMUNITY. 2021;54(2):259-275.e7Evren E; Ringqvist E; Tripathi KP; Sleiers N; Rives IC; Alisjahbana A; Gao Y; Sarhan D; Halle T; Sorini C; Lepzien R; Marquardt N; Michaelsson J; Smed-Sorensen A; Botling J; Karlsson MCI; Villablanca EJ; Willinger T
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(50):32005-32016Eisinger S; Sarhan D; Boura VF; Ibarlucea-Benitez I; Tyystjarvi S; Oliynyk G; Arsenian-Henriksson M; Lane D; Wikstrom SL; Kiessling R; Virgilio T; Gonzalez SF; Kaczynska D; Kanatani S; Daskalaki E; Wheelock CE; Sedimbi S; Chambers BJ; Ravetch JV; Karlsson MCI
- Article: JCI INSIGHT. 2020;5(5):130155Sarhan D; Wang J; Arvindam US; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
- Article: METHODS IN MOLECULAR BIOLOGY. 2019;1913:153-166Sarhan D; Miller JS
- Article: CANCER IMMUNOLOGY RESEARCH. 2018;6(7):766-775Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
- Article: BLOOD ADVANCES. 2018;2(12):1459-1469Sarha D; Brandt L; Felices M; Guldevall K; Lenvik T; Hinderlie P; Curtsinger J; Warlick E; Spellma SR; Blazar BR; Weisdorf DJ; Cooley S; Vallera DA; Onfelt B; Miller JS
- Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(6):1152-1162de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
- Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2018;67(3):483-494Bachanova V; Sarhan D; DeFor TE; Cooley S; Panoskaltsis-Mortari A; Blazar BR; Curtsinger JM; Burns L; Weisdorf DJ; Miller JS
- Article: CANCER RESEARCH. 2017;77(20):5664-5675Cichocki F; Valamehr B; Bjordahl R; Zhang B; Rezner B; Rogers P; Gaidarova S; Moreno S; Tuininga K; Dougherty P; McCullar V; Howard P; Sarhan D; Taras E; Schlums H; Abbot S; Shoemaker D; Bryceson YT; Blazar BR; Wolchko S; Cooley S; Miller JS
- Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2017;66(10):1333-1344Lovgren T; Sarhan D; Truxova I; Choudhary B; Maas R; Melief J; Nystrom M; Edback U; Vermeij R; Scurti G; Nishimura M; Masucci G; Karlsson-Parra A; Lundqvist A; Adamson L; Kiessling R
- Article: ONCOIMMUNOLOGY. 2017;6(8):e1338238Sarhan D; Leijonhufvud C; Murray S; Witt K; Seitz C; Wallerius M; Xie H; Ullen A; Harmenberg U; Lidbrink E; Rolny C; Andersson J; Lundqvist A
- Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):261-262Bachanova V; Sarhan D; Defor T; Cooley S; Panoskaltsis‐Mortari A
- Article: SCIENTIFIC REPORTS. 2016;6:37996Thuy TL; Ganesan S; Wagner AK; Sarhan D; Meinke S; Garbi N; Haemmerling G; Alici E; Karre K; Chambers BJ; Hoglund P; Kadri N
- Article: CANCER RESEARCH. 2016;76(19):5696-5706Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2015;45(6):1783-1793Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Osterborg A; Lundqvist A
- Article: CLINICAL CANCER RESEARCH. 2014;20(15):4096-4106Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(7):1643-1652Wennerberg E; Sarhan D; Carlsten M; Kaminskyy VO; D'Arcy P; Zhivotovsky B; Childs R; Lundqvist A
- Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2013;62(8):1359-1368Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2013;43(1):249-257Sarhan D; D'Arcy P; Wennerberg E; Lidén M; Hu J; Winqvist O; Rolny C; Lundqvist A
- Journal article: ONCOIMMUNOLOGY. 2012;1(7):1200-1201Kiessling R; Okita R; Mougiakakos D; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kono K
- Article: JOURNAL OF IMMUNOLOGY. 2012;188(5):2136-2145Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
- Show more
All other publications
- Preprint: BIORXIV. 2025Sun Y; Wan M; Kolbeinsdottir S; Wang K; Khare S; Gultekin O; Salehi S; Lehti K; Dasgupta R; Foukakis T; Enge M; Sarhan D
- Conference publication: 2024;:a1568Sarhan D; Heffinger L; Damdimopoulos A
- Preprint: BIORXIV. 2024Khan ZA; Ghorbani M; Heffinger L; Damdimopoulos A; Moro CF; Björnstedt M; Löhr J-M; Heuchel R; Chen MS; Sarhan D
- Preprint: BIORXIV. 2024Almazán NM; Román S; Sun Y; Bräutigam L; Pantalone MR; Stragliotto G; Gultekin O; Saheli S; Lehti K; Nauclér CS; Sarhan D
- Preprint: BIORXIV. 2024Sun Y; Rodgers-Furones A; Gultekin O; Khare S; Neo SY; Shi W; Galceran LM; Lam K-P; Dasgupta R; Fuxe J; Salehi S; Lehti K; Sarhan D
- Preprint: BIORXIV. 2024Silva C; Folkesson E; Foroogh F; Gower M; Kleberg L; Xi P; Sahran D; Bruchfeld J; Correia-Neves M; Källenius G; Sundling C
- Conference publication: 2023;:a1108Sun Y; Rodgers-Furones A; Suzuki S; Gultekin O; Galceran L; Salehi S; Lehti K; Sarhan D
- Conference publication: 2023;:a1103-a1104Almazan NM; Sarhan D
- Review: MATRIX BIOLOGY. 2023;121:217-228Closset L; Gultekin O; Salehi S; Sarhan D; Lehti K; Gonzalez-Molina J
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
- Preprint: SSRN ELECTRONIC JOURNAL. 2022Sarhan D; Eisinger S; Pelicano C; Fei H; Driescher C; Westberg K; Benitez II; Humoud R; Palano G; Li S; Carannante V; Önfelt B; Schlisio S; Ravetch JV; Heuchel R; Löhr MJ; Karlsson MCI
- Conference publication: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2021;9:A927Sarhan D; He F; Calandigary A; Malki E; Moro CF; Kaisso M; Olofsson-Sahl P; Melssen M; Lohr M; Karlsson M; Heuchel R
- Review: EUROPEAN JOURNAL OF CANCER. 2021;155:256-267Razaghi A; Poorebrahim M; Sarhan D; Bjornstedt M
- Preprint: BIORXIV. 2021Gultekin O; Gonzalez-Molina J; Hardell E; Moyano-Galceran L; Mitsios N; Mulder J; Kokaraki G; Isaksson A; Sarhan D; Lehti K; Carlson J
- Conference publication: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020;8:A431La Fleur L; Botling J; He F; Pelicano C; Palano G; Mezheyeuski A; Micke P; Ravetch J; Karlsson M; Sarhan D
- Conference publication: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2019;7Sarhan D
- Book chapter: CELL AND GENE THERAPIES: ADVANCES AND CONTROVERSIES IN HEMATOPOIETIC TRANSPLANTATION AND CELL THERAPY. 2019;p. 181-200Sarhan D; Miller JS
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):342Chrobok M; Dahlberg CIM; Sayitoglu C; Nahi H; Sarhan D; Gilljam M; Stellan B; Sutlu T; Duru AD; Alici E
- Conference publication: CANCER RESEARCH. 2017;77:3752Cichocki F; Valamehr B; Bjordahl R; Zhang B; Sarhan D; Cooley S; Blazar B; Rezner B; Rogers P; Green C; Abbot S; Shoemaker D; Wolchko S; Miller JS
- Conference publication: LEUKEMIA RESEARCH. 2017;55:S126Vallera DA; Felices M; Sarhan D; Brandt L; Guldevall K; Warlick ED; Cooley S; Weisdorf DJ; Onfelt B; Miller JS
- Conference publication: BLOOD. 2016;128(22):3030Bachanova V; Sarhan D; Defor TE; Cooley S; Panoskaltsis-Mortari A; Verneris MR; Blazar BR; Curtsinger J; Burns LJ; Weisdorf DJ; Miller JS
- Conference publication: BLOOD. 2016;128(22):1225Cichocki F; Valamehr B; Sarhan D; Zhang B; Cooley S; Verneris MR; Blazar BR; Bjordahl R; Rezner B; Rogers P; Green C; McKenna DH; Shoemaker D; Wolchko S; Miller JS
- Conference publication: BLOOD. 2016;128(22):4291Felices M; Sarhan D; Brandt L; Guldevall K; McElmurry R; Lenvik A; Chu S; Tolar J; Taras E; Spellman SR; Warlick ED; Verneris MR; Cooley S; Weisdorf D; Blazar BR; Onfelt B; Vallera D; Miller JS
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:511Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
- Meeting abstract: CANCER IMMUNOLOGY RESEARCH. 2016;4(1):b071Adamson L; Sarhan D; Choudhary B; Mellef J; Nystrom M; Edback U; Vermeij R; Scurti G; Nishimura M; Lundqvist A; Kiessling R; Lovgren T
- Review: FRONTIERS IN IMMUNOLOGY. 2015;6:605Dahlberg CIM; Sarhan D; Chrobok M; Duru AD; Alici E
- Conference publication: BLOOD. 2014;124(21):4140Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Osterborg A; Lundqvist A
- Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2014;15(10):18557-18573Sarhan D; D'Arcy P; Lundqvist A
- Doctoral thesis: 2014Sarhan D
- Conference publication: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2014;2(Suppl 3):p224Mao Y; Sarhan D; Poschke I; Lundqvist A; Kiessling R
- Show more
Grants
- Study sex immune dimorphism in the tumor microenvironmentCancer&Allergi fonden1 April 2024 - 1 April 2025
- Study the therapeutic potential of adaptive NK cells in solid tumorsRadiumhemmet Research funding1 January 2024 - 31 December 2026
- Study adaptive NK cells in cancerSwedish Cancer Society1 January 2024 - 1 January 2027
- Swedish Cancer Society1 January 2024NK cells are innate immune cells that are thought to lack memory but can kill stressed and uncontrolled cells, moreover, their activity correlates with a better prognosis in tumors that arise in tissues so-called. solid tumors. Our research focuses on a newly discovered immune cell called adaptive natural killer cell (aNK cells) a subtype of NK cells that have immunological memory of viral infections. We have previously reported that aNK cells have an ability to resist tumor inhibition mechanisms that include increasing checkpoint proteins. This means that the proteins that prevents white blood cells from doing their job is expressed at low levels. Immunotherapy is a form of treatment that has recently shown promising results in patients with metastatic cancer. Despite promising clinical results, less than 40% of patients still respond to this form of treatment. This is largely due to the fact that tumor and tumor-supporting cells can inhibit the immune system. aNK cells can unimpeded carry out the killing of tumor cells that are surrounded by tumor supporting cells in comparison with normal NK cells. Here we aim to investigate 1) strategies used by aNK cells to recognize tumors. 2) Study mechanisms that drive aNK cell memory. 3) Characterize aNK cells in solid tumors. Results from this study will lead to a new knowledge to understand aNK cells in solid tumors, with purpose to improve their tumor reactivity to serve as a new cancer immunotherapy. Here we will use models of aggressive tumors such as ovarian cancer, metastatic, breast cancer and melanoma. Patients with these tumor types are still in great need of effective treatment options. The long-term goal of this program is to promote basic and transnational knowledge to develop new immunotherapies.
- Sex immune dimorphism in cancerKI internal funding1 January 2023 - 1 January 2025
- Studies of newly discovered adaptive NK cells with therapeutic potential in solid tumorsRadiumhemmets Research funds1 January 2022 - 31 December 2024
- Targeting FPR2 as a novel approach for immunotherapy in pancreatic cancer female patients – Studies of sexual immune dimorphism in the tumor microenvironmentCentrum for innovative medicine1 January 2022 - 1 January 2025
- Study aNK cells in GBMKI doctoral studies funding1 July 2021 - 1 July 2025
- Study adaptive NK cell signaling in cancerSwedish Cancer Society1 February 2021 - 1 February 2027
- Studies of the newly discovered adaptive NK cells in cancerSwedish Cancer Society1 January 2021 - 31 December 2024
- Studies of newly discovered adaptive NK cells in cancer immunotherapyStiftelsen Clas Groschinsky Minnesfonds1 January 2021 - 31 December 2024
- New immunotherapy for pancreatic cancer by reprogramming macrophagesSjöberg foundation1 January 2021 - 1 January 2024
- Swedish Cancer Society1 January 2021NK cells are innate immune cells that are thought to have no memory but can kill stressed and uncontrolled cells, in addition their activity correlates with a better prognosis in tumors that arise in tissues so-called. solid tumors. Our research focuses on a newly discovered immune cell called adaptive natural killer cell (aNK cells) a subtype of NK cells that have immunological memory of viral infections. We have previously reported that aNK cells have an ability to resist tumor inhibition mechanisms that include an increase in checkpoint proteins. This means that the proteins that prevent the white blood cells from doing their job are expressed at low levels. Immunotherapy is a form of treatment that has recently shown promising results in patients with metastatic cancer. Despite promising clinical results, less than 40% of patients still respond to this form of treatment. This is largely due to the fact that tumor and tumor-supporting cells can inhibit the immune system. aNK cells can unimpededly carry out the killing of tumor cells that are surrounded by tumor supporting cells in comparison with normal NK cells. Here we aim to investigate 1) strategies used by aNK cells to recognize tumors. 2) Study mechanisms that drive aNK cell memory. 3) Characterize aNK cells in solid tumors. Results from this study will lead to new knowledge to understand aNK cells in solid tumors, with the aim of improving their tumor reactivity to serve as a new cancer immunotherapy. Here we will use models of aggressive tumors such as pancreatic cancer, lung cancer, ovarian cancer, metastatic breast cancer and melanoma. Patients with these tumor types are still in great need of effective treatment options. The long-term goal of this program is to advance basic and transnational knowledge to develop new immunotherapies.
- Decoding adaptive NK cell signalingJonas Söderquist's scholarship1 January 2020 - 1 January 2023
Employments
- Senior Lecturer, Department of Laboratory Medicine, Karolinska Institutet, 2025-
- Assistant Professor, Department of Laboratory Medicine, Karolinska Institutet, 2021-2025
Degrees and Education
- Docent, Karolinska Institutet, 2021
- Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2014
- Degree Of Master Of Medical Science 120 Credits, Karolinska Institutet, 2010